ZP Therapeutics bagged Healthcare Asia Pharma Awards 2024 for continuing medical education | Healthcare Asia Magazine

ZP Therapeutics bagged Healthcare Asia Pharma Awards 2024 for continuing medical education

It has engaged global medical experts and opinion makers to set up medical education events.

ZP Therapeutics, a division of Zuellig Pharma, brought home the Most Differentiated Service of the Year - Singapore category win at the recently held Healthcare Asia Pharma Awards 2024 for its successful execution of continuing medical education (CME) initiatives that have been recognised by various medical associations.

This comes amidst the company identifying evidence-informed clinical decision-making as a gap for the medical community in Asia. 

ZP Therapeutics worked with more than 30 global medical experts and opinion makers to set up a series of medical education events, covering breast and lung cancer, osteoporosis, type 2 diabetes, infectious disease, men’s health, and immunological disorders. Approximately 36 events were developed to engage more than 7,000 healthcare practitioners (HCP) through 200 hours of face-to-face and virtual CME and innovative skills-building workshops.

It is getting closer to the aspiration of being the most preferred partner for scientific collaborations in Asia, recognised for its efforts to bridge the scientific gap and upskilling the knowledge of relevant HCPs.

“By bringing global experts and clinical investigators in Asia, we are able to timely share important treatment guidelines to HCPs across countries and provide a forum for HCPs to engage with the experts. This exponentially multiplies the scientific sharing as the HCPs pursue to share information in their respective countries,” the company said.

Healthcare Asia Pharma Awards honours outstanding companies in Asia that have demonstrated unwavering commitment to innovation and excellence and have redefined pharmaceutical excellence.

The Healthcare Asia Pharma Awards is presented by Healthcare Asia Magazine. To view the full list of winners, click here. If you want to join the 2025 awards programme and be recognised for your organisation's innovative and unique initiatives that enhanced your business and remarkable contributions to the pharmaceutical industry, please contact Julie Anne Nuñez at [email protected].

Follow the link for more news on

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

Kejeniusan dalam ‘SuperApps’ untuk perawatan kesehatan adalah akses dan jangkauan

Rumah sakit yang merangkul digitalisasi tetap unggul dalam layanan kesehatan.

Rumah Sakit Kanker Dharmais memimpin inovasi pelayanan kanker di Indonesia

Direktur Utama RS Kanker Dharmais Soeko Werdi Nindito Daroekoesoemo mengungkapkan teknologi canggih dan tujuh program unggulan untuk perawatan kanker.

Healthway Cancer Care Hospital memajukan perawatan holistik dengan harga yang wajar

Rumah sakit mengharapkan program kualitas dan kelangsungan hidup yang melayani keseluruhan perjalanan pasien.

MakatiMed menuju perawatan bedah presisi dengan sistem robotik Da Vinci Xi

Teknologi ini memungkinkan teknik invasif minimal dalam bidang urologi, hepatobilier, kardiovaskular, toraks, kebidanan dan ginekologi, serta bedah umum.

Indonesia memperluas dukungan solusi kesehatan menggunakan AI

Kolaborasi dengan Google Cloud sejalan dengan cetak biru pemerintah untuk transformasi kesehatan digital.

Indonesia merancang rencana induk untuk pengembangan kesehatan terpadu

Rencana induk sektor kesehatan negara (RIBK) selaras dengan mandat Undang-Undang Kesehatan Nomor 17 Tahun 2023.

The Medical City membuka jalan bagi integrasi AI dalam layanan kesehatan lokal dan penelitian dengan Lunit

AI telah diintegrasikan ke dalam layanan mamografi dan rontgen dada di jaringan rumah sakit ini.

Mayapada Healthcare Group meraih prestasi besar di Healthcare Asia Awards 2024

Pendekatan holistik yang dilakukan oleh rumah sakit tersebut mendorongnya maju dan menjadi standar industri.

Rumah Sakit Kanker Dharmais meraih dua kemenangan di Healthcare Asia Awards 2024

Sumber daya manusia yang kompeten, layanan, fasilitas, dan infrastruktur unggul membantu rumah sakit memberikan perawatan pasien yang sangat baik.